Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BIOA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
42 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 3
151 filers reported a long position in BIOA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| a16z Capital Management, L.L.C. | $79.2M | 3.2M | Unchanged |
| BlackRock, Inc. | $69.8M | 2.8M | +25.6% |
| Cormorant Asset Management, LP | $58.6M | 2.4M | -17.3% |
| Sofinnova Investments, Inc. | $56.2M | 2.3M | Unchanged |
| Jupiter Topco LLC | $52.6M | 2.1M | — |
| Octagon Capital Advisors LP | $42.8M | 1.7M | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. | $41M | 1.7M | +1.3% |
| MPM BioImpact LLC | $40.9M | 1.7M | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $37.8M | 1.5M | +14% |
| Polar Capital Holdings Plc | $26.3M | 1.1M | -5.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.